
Annexon
(NASDAQ) ANNX
Annexon Financials at a Glance
Market Cap
$865.09M
Revenue (TTM)
$0.00
Net Income (TTM)
-$196.48M
EPS (TTM)
-$1.22
P/E Ratio
-4.34
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$5.30
Volume
94,717
Open
$5.29
Price
$5.30
Volume
94,717
Open
$5.29
Previous Close
$5.30
Daily Range
$5.26 - $5.59
52-Week Range
$1.85 - $7.18
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$5.30
Volume
94,717
Open
$5.29
Previous Close
$5.30
Daily Range
$5.26 - $5.59
52-Week Range
$1.85 - $7.18
Estimated Earnings Date
Aug 13, 2026
ANNX News
ANNX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Annexon
Industry
Biotechnology
Sector
Health CareEmployees
96
CEO
Douglas Love
Website
www.annexonbio.comHeadquarters
Brisbane, CA 94005, US
ANNX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-101.19%
Return on Capital
-90.99%
Return on Assets
-74.74%
Earnings Yield
-23.04%
Dividend Yield
0.00%
Payout Ratio
-0.95%
Stock Overview
Market Cap
$865.09M
Shares Outstanding
163.84M
Volume
94.72K
Avg. Volume
2.59M
Financials (TTM)
Gross Profit
-$1.90M
Operating Income
-$205.06M
EBITDA
-$193.41M
Operating Cash Flow
-$183.10M
Capital Expenditure
-$63.00K
Free Cash Flow
-$183.16M
Cash & ST Invst.
$225.03M
Total Debt
$25.43M
Annexon Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$957.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$865.09M
N/A
Market Cap/Employee
$8.16M
N/A
Employees
106
N/A
Net Income
-$44.14M
+18.8%
EBITDA
-$43.19M
+19.8%
Quarterly Fundamentals
Total Cash
$225.03M
-14.7%
Total Debt
$25.43M
-10.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$22.42M
-12.7%
Short Term Debt
$3.02M
+15.3%
Return on Assets
-74.74%
N/A
Return on Invested Capital
-90.35%
N/A
Free Cash Flow
-$46.80M
+6.6%
Operating Cash Flow
-$46.80M
+6.5%


